AUCTORES
Globalize your Research
Review Article | DOI: https://doi.org/10.31579/2640-1053/220
*Corresponding Author: Ankita Pandey. Department of Radiotherapy and Oncology, PGIMER, Chandigarh, India.
Citation: Ankita Pandey, (2024), Then and Now: Non metastatic Breast cancer: A Review Literature, J Cancer Research and Cellular Therapeutics, 8(8); DOI:10.31579/2640-1053/220
Copyright: © 2024, Ankita Pandey. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Received: 25 November 2024 | Accepted: 03 December 2024 | Published: 09 December 2024
Keywords: breast cancer; non- metastatic; breast conserving therapy; radiotherapy; brachytherapy boost; cosmetic outcome
Breast cancer is most common cancer worldwide among females. It is most thoroughly studied and investigated area in the field of oncology. It is disease of predominantly young females and has well known etiological factors. The management has evolved from extensive surgery in the past to the limited surgical excision. The awareness among females has also led to earl diagnosis and prompt management. The critical area of interest now lies in the field of radiation therapy where different techniques are used to enhance the local control and improve the cosmesis. This review article focuses on general outline of the anatomy, clinical features, diagnosis and management focusing on the evolution of the radiotherapy techniques especially in early stage breast cancer.
The term “Cancer” is derived from the Greek word “Karkinos” (for crab) which refers to a generic non-communicable disease (NCD) characterized by growth of malignant (cancerous or neo-plasms) abnormal cells (tumor/ lump) in any part of the human body. In spite of good advancements for diagnosis and treatment, cancer is still a big threat to our society.
The female breast lies on the anterior chest wall superficial to the pectoralis major muscle. The breast extends from the midline to near the mid-axillary line and cranial caudally from the second anterior rib to the sixth anterior rib. The upper outer quadrant of the breast extends into the region of the low axilla and is frequently referred to as the axillary tail of Spence. This anatomical feature results in the upper outer quadrant of the breast containing a greater percentage of total breast tissue compared with the other quadrants, and, therefore, a greater percentage of breast cancers occur in this anatomical location. The breast parenchyma is intermixed with connective tissue, which has a rich vascular and lymphatic network.
Extent
Figure 1: Coronal section of the breast and the inner structure
The predominant lymphatic drainage of the breast is to axillary lymph nodes, which is commonly described in three levels, based on the relation of the lymph node regions to the pectoralis minor muscle.
| Lymph node level | Anatomic relation |
| Level I | Caudal and lateral to the pectoralis minor muscle |
| Level II | Below the pectoralis minor muscle |
| Level III | Cranial and medial to the pectoralis minor muscle |
Table 1: Lymph nodal levels of breast and its relation to the anatomical structures
Other group of lymph nodes involved are-
Cancer of the breast is one of the most common cancers among women worldwide. In 2018, this was about 11.6% of the total cancer cases in both sexes. In India, breast cancer is now most common cancer and accounts for 14% of all cancer cases. It has been estimated that in 2018, worldwide there were 2088849 cases of breast cancer, and 626679 deaths due to breast cancer. A large proportion of the global burden occurs in the developed countries where it accounts for almost 24.2% of all female cancers. Although breast cancer incidence is high in developed countries compared to India, the mortality rate in India is high (6.6% vs 12.1%)[1]. India continues to have a low survival rate for breast cancer, with only 66.1% women diagnosed with the disease between 2010 and 2014 surviving, a Lancet study found. According to estimates, at least 17,97,900 women in India may have breast cancer by 2020 [2]. India is the largest country among all countries of Southern Asia. It has a population of 432.20 million women aged 15 years and older who are at risk of developing breast cancer. Current estimates of GLOBOCAN 2018 indicate that every year in India 162468 women are diagnosed with breast cancer and 87090 die from the disease. Breast cancer in India varies from as low as 5 per 100,000 female population per year in rural areas to 30 per 100,000 female population per year in urban areas [3].
| Indian cities | Breast cancer percentage | Crude rate per 100000 | Age adjusted rank per 100000 |
| Mumbai | 28.8 | 33.6 | 33.6 |
| Bangalore | 27.2 | 29.3 | 34.4 |
| Chennai | 30.7 | 40.6 | 37.9 |
| Thiruvananthapuram | 28.5 | 43.9 | 33.7 |
| Dibrugarh | 19 | 12.7 | 13.9 |
| New Delhi | 28.6 | 34.8 | 41 |
| Barshi rural | 20 | 13.2 | 12.4 |
Table 2: Ranking and rates for breast cancer (NCRP 2012)
The majority of patients with T1 or T2 breast cancers presents with a painless or slightly tender breast mass or have an abnormal screening mammogram. Patients with more advanced tumors may have breast tenderness, skin changes, bloody nipple discharge, or occasionally change in the shape and size of the breast. Rarely, patients may present with axillary lymphadenopathy or even distant metastasis. The duration of clinical symptoms may vary from weeks to years. Olivotto et al.,found that delays in diagnosis of 6 to 12 months led to an increased tumor size and more lymph node metastases compared with patients diagnosed within 2 to 4 weeks of an abnormal screening mammogram[4].
Age incidence rates in India suggest that the disease peaks at a younger age (eg, 40-50 years) than in Western countries and as a result, the majority of new diagnoses occur in pre-menopausal women. Raina et al, found the mean age at diagnosis was 47 years and 49.7% were premenopausal, 96% presented with lump[5]. Most advanced primary tumors are associated with axillary lymph node involvement. Local disease progression can lead to ulceration of skin, pain, bleeding infection. Progression of untreated regional lymphatic disease can cause pain, brachial plexopathy, arm edema, obstruction and thrombosis of brachial vasculature and skin ulceration.
Clinical evaluation and Diagnostic work- up
Includes age, early menarche, late menopause, prolonged use of HRT, family history, lower parity, BRCA1 or 2 mutation[6]. MacMahaon et al., demonstrated a nearly linear relationship between relative risk of breast cancer and age at first child birth with women age 20 to 25 having nearly 50%reduction in relative risk compared to nulliparous women. They also demonstrated that in comparison to women having menopause between 45 to 54 (relative risk 1), women with menopause before 45 have a relative risk of 0.73% and women with menopause after 54 have a relative risk of 1.48[7].
Women with a second degree relative with breast cancer have risk of 1.5 and for women with first degree relative the risk is about 1.7 to 2.5. Between 20 to 25% of women diagnosed with breast cancer have a positive family history and approximately 10% have an autosomal dominant pattern of inheritance[8]. A pooled analysis of prospective studies by Van den et al in 2000 demonstrated risk of breast cancer to be 30% higher in post menopausal women with BMI over 31 compared to women with BMI of 20.The higher risk with increased BMI in post menopausal women is likely due to higher estradiol levels associated with increased adipose tissue and aromatase activity, involved in conversion of androgen to estradiol [9]. Other important risk factors being personal history of breast cancer, radiation exposure to chest wall alcohol consumption, increased mammographic density.
Breast cancer screening guidelines are given by-
| Age group | ACS (2003) GUIDELINE |
| 20-39 yr | BSE optional; CBE every 3 years. |
| 40-49 yr | Annual mammography and CBE from 40 years. |
| >49yr | Annual mammography and CBE as long as a woman is in reasonably good health. |
| Age group | NCI (2002) GUIDELINE |
| 20-39 yr | No recommendation |
| 40-49 yr | Mammography every 1–2 years |
| >49yr | Mammography every 1–2 years |
Preoperative assessment of tumor size is commonly estimated by inspection and palpation. The accuracy of clinical assessment is influenced by patient and observer factors and is not useful for clinically occult tumors and is prone to overestimating actual tumor size[10]. Clinical examination has been found to have low sensitivity and specificity (36% and 39% respectively) in the evaluation of axillary lymph nodes. It cannot assess the number of nodes, nodes in depth and nodes of small size. Also it cannot distinguish between reactive and malignant nodes or detect extra capsular extension [11]. Physical examination alone has long been recognized as inaccurate in predicting axillary metastases, and is associated with false negative and false positive rates of 25% to 38%. Internal mammary group of lymph nodes are clinically not evaluable [12].
Mammograms are by far the most common breast cancer screening tool and bilateral mammograms should be performed routinely in the work-up of the breast cancer patient. Mammography uses low energy x-rays to examine the compressed breast. Contrast in mammography results from differences in the absorption or attenuation of x-rays by different tissues in the breast. This technique has been in use for about 40 years and is the current gold standard for diagnosing breast disease. In mammography, lymph nodes are visible on standard projections, and it is possible to differentiate between normal and pathological nodes. Normal nodes are moderately attenuated, the fatty hilus being seen as a low attenuated part. Normal nodes can vary in size from a few millimeters to several centimeters. Pathological nodes are of greater density than normal nodes and the hilum disappears. The form also becomes more expanded from oval to round but the size is not necessarily increased. However, in the standard projections, only part of axilla can be seen, and during exposure of the mammogram, pathological nodes can be pushed outside the mammographic image. Mammography is therefore not a reliable method in axillary lymph node imaging. The Breast Imaging Reporting and Data Systems (BI-RADS) classification system, outlined below has been widely adopted in classifying mammograms with respect to appropriate follow-up and/or intervention [13].
Table 3: American College of Radiology Breast Imaging Reporting and Data Systems (BI-RADS) Assessment Categorize Mammography
| Category 1 Negative | There is nothing to comment on. The breasts are symmetric and no masses, architectural disturbances, or suspect calcifications are present. |
| Category 2 Benign finding | This is also a negative mammogram, but the interpreter may wish to describe a finding. Involuting, calcified fibroadenomas, multiple secretory calcifications, fat-containing lesions such as oil cysts, lipomas, galactoceles, and mixed-density hamartomas all have characteristic appearances, and may be labeled with confidence. The interpreter might wish to describe intramammary lymph nodes, implants, and the like, while still concluding that there is no mammographic evidence of malignancy. |
| Category 3 Probably benign finding short-interval follow-up suggested | A finding placed in this category should have a very high probability of being benign. It is not expected to change over the follow-up interval, but the radiologist would prefer to establish its stability. Data are becoming available that shed light on the efficacy of short-interval follow-up. At present, most approaches are intuitive. These will likely undergo future modification as more data accrue as to the validity of an approach, the interval required, and the type of findings that should be followed. |
| Category 4 Suspicious abnormality biopsy should be considered | These are lesions that do not have the characteristic morphologies of breast cancer but have a definite probability of being malignant. The radiologist has sufficient concern to urge a biopsy. If possible, the relevant probabilities should be cited so that the patient and her physician can make the decision on the ultimate course of action. |
| Category 5 Highly suggestive of malignancy appropriate action should be taken | These lesions have a high probability of being cancer. |
Category 0
| Finding for which additional imaging evaluation is needed. This is almost always used in a screening situation and should rarely be used after a full imaging workup. A recommendation for additional imaging evaluation includes the use of spot compression, magnification, special mammographic views, ultrasound, and so forth. |
Ultrasound, also called sonography, uses high frequency sound waves to penetrate breast tissue and measures the reflection from different tissues in the breast. Due to inability to consistently detect early signs of cancer such as microcalcifications, ultrasound is not routinely used for breast cancer screening but primarily to distinguish solid tumors from fluid filled cysts, evaluate suspected carcinomas in mammographically dense breasts and for biopsy guidance[14]. Sonography is an important adjunct to mammography to identify, characterize, and localize breast lesions, and it has the added advantage of not being limited by dense breasts. It also has no radiation or compression. Consequently, sonography is more effective for women younger than 35 years of age[15]. Breast ultrasound examinations can obtain any sectional image of breast, and observe the breast tissues in real-time and dynamically. Ultrasound imaging can depict small, early-stage malignancies of dense breasts, which is difficult for mammography to achieve.
Magnetic Resonance Imaging (MRI) is emerging as a promising tool for screening breast cancer especially among high risk women. MRI has also demonstrated greater sensitivity in detecting small (less than 1 cm) lesions and succeeds in certain scenarios where other imaging modalities are challenged, such as imaging dense breasts, the post-operative breast and augmented breasts. In a review of MRI in the management of breast cancer, Hylton summarized the potential for the current use of MRI: to complement mammography in screening, for differential diagnosis of questionable findings on physical examination, mammography, and ultrasound; and assessment of response in the Neoadjuvant treatment of breast cancers[16]. The American Society of Breast Surgeons has outlined indications for the use of breast MRI. These include axillary nodal metastasis with unknown primary, determination of ipsilateral or contralateral disease in newly diagnosed breast cancer patients with invasive lobular cancer, difficult mammographic assessments, monitoring response to Neoadjuvant therapy, screening of high-risk patients, and evaluation of suspicious clinical findings or imaging studies with indeterminate work-ups. Drawbacks of MRI include moderate diagnostic specificity, false-positive findings requiring additional biopsies, patient distress, prolongation of the pre surgical work-up and the potential for overestimation of tumor size and higher cost[17].
Breast Cancer Diagnosis
Histopathological or cytological examination is the only definitive way to determine whether a mass is malignant or benign. As such, abnormalities detected with any of the afore-discussed techniques might be queried by biopsy. Common forms of breast biopsy include fine needle aspiration (FNA), core biopsy, vacuum assisted biopsy and open surgical biopsy. Breast biopsy of any suspicious mass is mandatory. The biopsy usually can be done using local anesthesia; the patient should be informed of the nature of the lesion to allow for her greater participation in therapeutic decisions. There has been no evidence that delay in treatment up to 2 weeks after biopsy worsens prognosis[18].
Prognostic factors in breast cancer
In patients of carcinoma breast undergoing single or multimodality treatment, outcome of treatment depends on various prognostic factors present before treatment.
The prognostic factors are
Stage at diagnosis is the best predictor of prognosis. Early stage breast cancer is curable in most patients by surgery +/- radiotherapy, with 5-year survival of 95%. Size of tumor is another prognostic factor in carcinoma breast. According to Carter et al., survival rates varied from 45.5% for tumor diameters equal to or greater than 5 cm with positive axillary nodes to 96.3% for tumors less than 2 cm and with no involved nodes. The relation between tumor size and lymph node status was investigated in detail. Tumor diameter and lymph node status were found to act as independent but additive prognostic indicators. As tumor size increased, survival decreased regardless of lymph node status; and as lymph node involvement increased, survival status also decreased regardless of tumor size. A linear relation was found between tumor diameter and the percent of cases with positive lymph node involvement[19].
Rosen et al., found a close correlation between tumor size and recurrence free survival[20].
| Tumor size | Recurrence free survival |
| <1cm> | 88% |
| 1.1 to 3cm | 72% |
| 3.1 to 5cm | 59% |
Table 4: Corelation of tumor size and recurrence free survival according to Rosen et al.
According to the number of axillary lymph nodes involved, patients are grouped into four prognostic categories
Although up to 30% to 40% of T1 or T2 clinically node-negative breast cancers may have pathologically involved lymph nodes, data from NSABP-04 suggest that less than half of clinically negative but pathologically positive axilla will experience a clinical relapse in the axilla.
Tumor Location | Axillary lymph node status | Rate of involvement of axillary lymph node |
| Medial/ central | 0 + ALN 1-3 + ALN 4-6 + ALN ≥7 + ALN | 6% (27/428) 26% (41/160) 43% (21/49) 40% (44/110) |
| Lateral | 0 + ALN 1-3 + ALN 4-6 + ALN ≥7 + ALN | 3% (12/456) 14% (34/238) 20% (18/90) 43% (63/148) |
Breast cancer is now considered to be a systemic disease from the outset, with most patients with early breast cancer developing metastases whatever the treatment undertaken. The need for and selection of therapy is based on a number of prognostic & predictive factors. They include tumor histology, clinical and pathologic characteristics of the primary tumor, axillary node status, tumor hormone receptor content, tumor HER2 receptor, presence or absence of detectable metastatic disease, patient comorbid conditions, patient age and menopausal status. Breast cancer therapy comprises local treatments and systemic treatments and often a combination of both. Local treatments include surgery and radiation. The aim of local treatments is to eradicate the disease at source or the primary tumor. Systemic treatments such as chemotherapy and hormone therapy are generally directed against the metastasis as well as locally.
Chemotherapy in non-metastatic breast cancer:
Even following effective local treatment, many patients develop metastasis over time and improvements in local control have been shown to provide, at best, only a small decrease in distant metastasis[18,21]. This was thought to be because of the concept of micrometastasis at the time of initial presentation. This led to the generation of the concept of systemic therapy for accomplishing long term improvement in the outlook of the disease.
The NSABP (National Surgical Adjuvant Breast & Bowel Project) evaluated the effect of adding cyclophosphamide to methotrexate and 5 fluorouracil (CMF) in the B-19 study. Estrogen negative (ER) negative patients underwent 6 months of treatment with either CMF or MF after surgery. Disease free survival (DFS) rates were statistically significantly higher for those taking CMF (82 vs 73%, p < 0>
C9344 (Henderson C et al , 2003)[24] | B28 (Mamounas EP et al, 2003)[25] | C9741 (Nabholtz JM et al, 2002)[26] | BCIRG 001 (Nabholtz JM et al, 2001)[27] | |
| N | 3170 | 3060 | 2005 | 1491 |
| Median follow-up | 69 months | 65 months | 36 months | 33 months |
| Superior Arm | AC --> P | AC --> P | AC --> P or A --> P --> C every 2 weeks | DAC |
| DFS Hazard Ratio | 0.83 (p = .0098) | 0.83 (P = 0.008) | 0.74 (P = .01) | 0.68 (P = .0002) |
| Death Hazard Ratio | 0.82 (p = .0098) | NS | 0.69 (P = .013) | 0.76 (P = .049) |
Table 5: Comparison of Breast Cancer Trials Evaluating Taxanes
Hormonal therapy in non metastatic breast cancer:
Estrogen, a hormone produced by the ovaries, promotes the growth of many breast cancers. Women whose breast cancers test positive for estrogen receptors can be given hormone therapy to block the effects of estrogen on the growth of breast cancer cells. Tamoxifen, the most common antiestrogen drug, is effective in both postmenopausal and premenopausal patients whose cancers are positive for hormone receptors. Recurrence and survival benefits generally increase with longer duration of tamoxifen use and have been shown to persist for at least 10 years following treatment[28].
Preliminary results of the ATLAS (Adjuvant Tamoxifen, Longer Against Shorter) International randomized trial of 10 versus 5 years of adjuvant tamoxifen among 11500 women showed that continuation of tamoxifen beyond the first 5 years reduces recurrence over the next few years, but further follow-up is needed to assess reliably the longer-term effects on recurrence and the net effects, if any, on mortality[29].
More recently, Trastuzumab has been shown to be effective in early-stage breast cancer that overexpresses HER2. The combined results of two large trials indicate that adding Trastuzumab to standard chemotherapy for early-stage HER2 positive breast cancer reduced the risk of recurrence and death by 52% and 33%, respectively, compared to chemotherapy alone[30]. In 2006, the FDA approved Trastuzumab for all HER2 positive breast cancers. All invasive breast cancers should be tested for the HER2 protein in order to identify women who would benefit from this therapy.
Surgery:
The primary goal of breast cancer surgery is to remove the tumor from the breast and to assess the stage of disease. The various surgical options are:
Lumpectomy - In lumpectomy, only cancerous tissue plus a rim of normal tissue is removed.
Simple/Total mastectomy - includes removal of the entire breast.
Radical mastectomy- Radical mastectomy is rarely used due to the proven effectiveness of less aggressive and disfiguring surgeries.
Modified radical mastectomy- This includes removal of the entire breast and lymph nodes under the arm, but does not include removal of the underlying chest wall muscle, as with a radical mastectomy.
Breast conserving therapy in early stage breast cancer cases
Breast conserving therapy include
Wide local excision with clear margins
Axillary lymph node dissection
Irradiation to whole breast with tumor bed boost or partial breast irradiation
The earliest prospective trial by Atkins et al in 1972 comparing breast conservation with radical mastectomy which included 370 women with stage I and II breast cancer showed no survival benefit for stage I disease, in stage II the recurrence rates and distant metastasis were higher in the group treated with local excision followed by irradiation. The EORTC Breast Cancer Cooperative Group comparing radical mastectomy with breast conservation showed actuarial 8 years local control was similar in both arms. The U.S. National Cancer Institute reported results of randomised study in T1-2/N0/M0 breast cancer treated with modified radical mastectomy or breast conservation, there was no difference with regard to overall survival, with median follow up of 18.4 years. In1971, the National Surgical Adjuvant Breast and Bowel Project (NSABP) initiated the B-04 study, a randomized clinical trial conducted to resolve controversy over the surgical management of breast cancer. The 25-year findings from that study showed that there was no significant difference in survival between women treated with the Halsted radical mastectomy and those treated with less extensive surgery[12]. NSABPB-06 TRIAL evaluated the efficacy of breast-conserving surgery in women with stage I or II breast tumors that were 4 cm or less in diameter. The outcome for women who were treated with lumpectomy alone or with lumpectomy and postoperative breast irradiation was compared with that for similar women who were treated with total mastectomy. There was no significant differences in survival among the women in the three treatment groups and demonstrated a significant decrease in the rate of recurrent cancer in the ipsilateral breast after lumpectomy plus irradiation[31]. Bartelink et al., studied the long-term impact of a boost radiation dose on local control, fibrosis, and overall survival for patients with stage I and II breast cancer who underwent breast conserving therapy. They concluded that After a median follow-up period of 10.8 years, a boost dose of 16 Gy led to improved local control in all age groups, but no difference in survival at 10 years, the cumulative incidence of local recurrence was 10.2% versus 6.2% for the no boost and the boost group, respectively (P < .0001). Severe fibrosis was statistically significantly increased (P <.0001) in the boost group, with a 10-year rate of 4.4% versus 1.6% in the no boost group (P<.0001). Survival at 10 years was 82% in both arms[32,33]. The meta-analysis of the Early Breast Cancer Trialists’ Collaborative Group (EBCTCG) revealed the need for radiotherapy after tumorectomy by showing that breast irradiation reduced the 5-year local recurrence rate from 26% to 7%.
The UK Standardisation of Breast Radiotherapy (START) Trial A randomized 2236 women with early breast cancer (pT1-3a pN0-1 M0) between 1998 and 2002, to receive 50 Gy in 25 fractions of 2.0 Gy versus 41.6 Gy or 39 Gy in 13 fractions of 3.2 Gy or 3.0 Gy over 5 weeks after primary surgery. After a median follow up of 5.1 years the rate of local-regional tumor relapse at 5 years was 3.6
Nil
There are no conflicts of interest
Clearly Auctoresonline and particularly Psychology and Mental Health Care Journal is dedicated to improving health care services for individuals and populations. The editorial boards' ability to efficiently recognize and share the global importance of health literacy with a variety of stakeholders. Auctoresonline publishing platform can be used to facilitate of optimal client-based services and should be added to health care professionals' repertoire of evidence-based health care resources.
Journal of Clinical Cardiology and Cardiovascular Intervention The submission and review process was adequate. However I think that the publication total value should have been enlightened in early fases. Thank you for all.
Journal of Women Health Care and Issues By the present mail, I want to say thank to you and tour colleagues for facilitating my published article. Specially thank you for the peer review process, support from the editorial office. I appreciate positively the quality of your journal.
Journal of Clinical Research and Reports I would be very delighted to submit my testimonial regarding the reviewer board and the editorial office. The reviewer board were accurate and helpful regarding any modifications for my manuscript. And the editorial office were very helpful and supportive in contacting and monitoring with any update and offering help. It was my pleasure to contribute with your promising Journal and I am looking forward for more collaboration.
We would like to thank the Journal of Thoracic Disease and Cardiothoracic Surgery because of the services they provided us for our articles. The peer-review process was done in a very excellent time manner, and the opinions of the reviewers helped us to improve our manuscript further. The editorial office had an outstanding correspondence with us and guided us in many ways. During a hard time of the pandemic that is affecting every one of us tremendously, the editorial office helped us make everything easier for publishing scientific work. Hope for a more scientific relationship with your Journal.
The peer-review process which consisted high quality queries on the paper. I did answer six reviewers’ questions and comments before the paper was accepted. The support from the editorial office is excellent.
Journal of Neuroscience and Neurological Surgery. I had the experience of publishing a research article recently. The whole process was simple from submission to publication. The reviewers made specific and valuable recommendations and corrections that improved the quality of my publication. I strongly recommend this Journal.
Dr. Katarzyna Byczkowska My testimonial covering: "The peer review process is quick and effective. The support from the editorial office is very professional and friendly. Quality of the Clinical Cardiology and Cardiovascular Interventions is scientific and publishes ground-breaking research on cardiology that is useful for other professionals in the field.
Thank you most sincerely, with regard to the support you have given in relation to the reviewing process and the processing of my article entitled "Large Cell Neuroendocrine Carcinoma of The Prostate Gland: A Review and Update" for publication in your esteemed Journal, Journal of Cancer Research and Cellular Therapeutics". The editorial team has been very supportive.
Testimony of Journal of Clinical Otorhinolaryngology: work with your Reviews has been a educational and constructive experience. The editorial office were very helpful and supportive. It was a pleasure to contribute to your Journal.
Dr. Bernard Terkimbi Utoo, I am happy to publish my scientific work in Journal of Women Health Care and Issues (JWHCI). The manuscript submission was seamless and peer review process was top notch. I was amazed that 4 reviewers worked on the manuscript which made it a highly technical, standard and excellent quality paper. I appreciate the format and consideration for the APC as well as the speed of publication. It is my pleasure to continue with this scientific relationship with the esteem JWHCI.
This is an acknowledgment for peer reviewers, editorial board of Journal of Clinical Research and Reports. They show a lot of consideration for us as publishers for our research article “Evaluation of the different factors associated with side effects of COVID-19 vaccination on medical students, Mutah university, Al-Karak, Jordan”, in a very professional and easy way. This journal is one of outstanding medical journal.
Dear Hao Jiang, to Journal of Nutrition and Food Processing We greatly appreciate the efficient, professional and rapid processing of our paper by your team. If there is anything else we should do, please do not hesitate to let us know. On behalf of my co-authors, we would like to express our great appreciation to editor and reviewers.
As an author who has recently published in the journal "Brain and Neurological Disorders". I am delighted to provide a testimonial on the peer review process, editorial office support, and the overall quality of the journal. The peer review process at Brain and Neurological Disorders is rigorous and meticulous, ensuring that only high-quality, evidence-based research is published. The reviewers are experts in their fields, and their comments and suggestions were constructive and helped improve the quality of my manuscript. The review process was timely and efficient, with clear communication from the editorial office at each stage. The support from the editorial office was exceptional throughout the entire process. The editorial staff was responsive, professional, and always willing to help. They provided valuable guidance on formatting, structure, and ethical considerations, making the submission process seamless. Moreover, they kept me informed about the status of my manuscript and provided timely updates, which made the process less stressful. The journal Brain and Neurological Disorders is of the highest quality, with a strong focus on publishing cutting-edge research in the field of neurology. The articles published in this journal are well-researched, rigorously peer-reviewed, and written by experts in the field. The journal maintains high standards, ensuring that readers are provided with the most up-to-date and reliable information on brain and neurological disorders. In conclusion, I had a wonderful experience publishing in Brain and Neurological Disorders. The peer review process was thorough, the editorial office provided exceptional support, and the journal's quality is second to none. I would highly recommend this journal to any researcher working in the field of neurology and brain disorders.
Dear Agrippa Hilda, Journal of Neuroscience and Neurological Surgery, Editorial Coordinator, I trust this message finds you well. I want to extend my appreciation for considering my article for publication in your esteemed journal. I am pleased to provide a testimonial regarding the peer review process and the support received from your editorial office. The peer review process for my paper was carried out in a highly professional and thorough manner. The feedback and comments provided by the authors were constructive and very useful in improving the quality of the manuscript. This rigorous assessment process undoubtedly contributes to the high standards maintained by your journal.
International Journal of Clinical Case Reports and Reviews. I strongly recommend to consider submitting your work to this high-quality journal. The support and availability of the Editorial staff is outstanding and the review process was both efficient and rigorous.
Thank you very much for publishing my Research Article titled “Comparing Treatment Outcome Of Allergic Rhinitis Patients After Using Fluticasone Nasal Spray And Nasal Douching" in the Journal of Clinical Otorhinolaryngology. As Medical Professionals we are immensely benefited from study of various informative Articles and Papers published in this high quality Journal. I look forward to enriching my knowledge by regular study of the Journal and contribute my future work in the field of ENT through the Journal for use by the medical fraternity. The support from the Editorial office was excellent and very prompt. I also welcome the comments received from the readers of my Research Article.
Dear Erica Kelsey, Editorial Coordinator of Cancer Research and Cellular Therapeutics Our team is very satisfied with the processing of our paper by your journal. That was fast, efficient, rigorous, but without unnecessary complications. We appreciated the very short time between the submission of the paper and its publication on line on your site.
I am very glad to say that the peer review process is very successful and fast and support from the Editorial Office. Therefore, I would like to continue our scientific relationship for a long time. And I especially thank you for your kindly attention towards my article. Have a good day!
"We recently published an article entitled “Influence of beta-Cyclodextrins upon the Degradation of Carbofuran Derivatives under Alkaline Conditions" in the Journal of “Pesticides and Biofertilizers” to show that the cyclodextrins protect the carbamates increasing their half-life time in the presence of basic conditions This will be very helpful to understand carbofuran behaviour in the analytical, agro-environmental and food areas. We greatly appreciated the interaction with the editor and the editorial team; we were particularly well accompanied during the course of the revision process, since all various steps towards publication were short and without delay".
I would like to express my gratitude towards you process of article review and submission. I found this to be very fair and expedient. Your follow up has been excellent. I have many publications in national and international journal and your process has been one of the best so far. Keep up the great work.
We are grateful for this opportunity to provide a glowing recommendation to the Journal of Psychiatry and Psychotherapy. We found that the editorial team were very supportive, helpful, kept us abreast of timelines and over all very professional in nature. The peer review process was rigorous, efficient and constructive that really enhanced our article submission. The experience with this journal remains one of our best ever and we look forward to providing future submissions in the near future.
I am very pleased to serve as EBM of the journal, I hope many years of my experience in stem cells can help the journal from one way or another. As we know, stem cells hold great potential for regenerative medicine, which are mostly used to promote the repair response of diseased, dysfunctional or injured tissue using stem cells or their derivatives. I think Stem Cell Research and Therapeutics International is a great platform to publish and share the understanding towards the biology and translational or clinical application of stem cells.
I would like to give my testimony in the support I have got by the peer review process and to support the editorial office where they were of asset to support young author like me to be encouraged to publish their work in your respected journal and globalize and share knowledge across the globe. I really give my great gratitude to your journal and the peer review including the editorial office.
I am delighted to publish our manuscript entitled "A Perspective on Cocaine Induced Stroke - Its Mechanisms and Management" in the Journal of Neuroscience and Neurological Surgery. The peer review process, support from the editorial office, and quality of the journal are excellent. The manuscripts published are of high quality and of excellent scientific value. I recommend this journal very much to colleagues.
Dr.Tania Muñoz, My experience as researcher and author of a review article in The Journal Clinical Cardiology and Interventions has been very enriching and stimulating. The editorial team is excellent, performs its work with absolute responsibility and delivery. They are proactive, dynamic and receptive to all proposals. Supporting at all times the vast universe of authors who choose them as an option for publication. The team of review specialists, members of the editorial board, are brilliant professionals, with remarkable performance in medical research and scientific methodology. Together they form a frontline team that consolidates the JCCI as a magnificent option for the publication and review of high-level medical articles and broad collective interest. I am honored to be able to share my review article and open to receive all your comments.
“The peer review process of JPMHC is quick and effective. Authors are benefited by good and professional reviewers with huge experience in the field of psychology and mental health. The support from the editorial office is very professional. People to contact to are friendly and happy to help and assist any query authors might have. Quality of the Journal is scientific and publishes ground-breaking research on mental health that is useful for other professionals in the field”.
Dear editorial department: On behalf of our team, I hereby certify the reliability and superiority of the International Journal of Clinical Case Reports and Reviews in the peer review process, editorial support, and journal quality. Firstly, the peer review process of the International Journal of Clinical Case Reports and Reviews is rigorous, fair, transparent, fast, and of high quality. The editorial department invites experts from relevant fields as anonymous reviewers to review all submitted manuscripts. These experts have rich academic backgrounds and experience, and can accurately evaluate the academic quality, originality, and suitability of manuscripts. The editorial department is committed to ensuring the rigor of the peer review process, while also making every effort to ensure a fast review cycle to meet the needs of authors and the academic community. Secondly, the editorial team of the International Journal of Clinical Case Reports and Reviews is composed of a group of senior scholars and professionals with rich experience and professional knowledge in related fields. The editorial department is committed to assisting authors in improving their manuscripts, ensuring their academic accuracy, clarity, and completeness. Editors actively collaborate with authors, providing useful suggestions and feedback to promote the improvement and development of the manuscript. We believe that the support of the editorial department is one of the key factors in ensuring the quality of the journal. Finally, the International Journal of Clinical Case Reports and Reviews is renowned for its high- quality articles and strict academic standards. The editorial department is committed to publishing innovative and academically valuable research results to promote the development and progress of related fields. The International Journal of Clinical Case Reports and Reviews is reasonably priced and ensures excellent service and quality ratio, allowing authors to obtain high-level academic publishing opportunities in an affordable manner. I hereby solemnly declare that the International Journal of Clinical Case Reports and Reviews has a high level of credibility and superiority in terms of peer review process, editorial support, reasonable fees, and journal quality. Sincerely, Rui Tao.
Clinical Cardiology and Cardiovascular Interventions I testity the covering of the peer review process, support from the editorial office, and quality of the journal.
Clinical Cardiology and Cardiovascular Interventions, we deeply appreciate the interest shown in our work and its publication. It has been a true pleasure to collaborate with you. The peer review process, as well as the support provided by the editorial office, have been exceptional, and the quality of the journal is very high, which was a determining factor in our decision to publish with you.
The peer reviewers process is quick and effective, the supports from editorial office is excellent, the quality of journal is high. I would like to collabroate with Internatioanl journal of Clinical Case Reports and Reviews journal clinically in the future time.
Clinical Cardiology and Cardiovascular Interventions, I would like to express my sincerest gratitude for the trust placed in our team for the publication in your journal. It has been a true pleasure to collaborate with you on this project. I am pleased to inform you that both the peer review process and the attention from the editorial coordination have been excellent. Your team has worked with dedication and professionalism to ensure that your publication meets the highest standards of quality. We are confident that this collaboration will result in mutual success, and we are eager to see the fruits of this shared effort.
Dear Dr. Jessica Magne, Editorial Coordinator 0f Clinical Cardiology and Cardiovascular Interventions, I hope this message finds you well. I want to express my utmost gratitude for your excellent work and for the dedication and speed in the publication process of my article titled "Navigating Innovation: Qualitative Insights on Using Technology for Health Education in Acute Coronary Syndrome Patients." I am very satisfied with the peer review process, the support from the editorial office, and the quality of the journal. I hope we can maintain our scientific relationship in the long term.
Dear Monica Gissare, - Editorial Coordinator of Nutrition and Food Processing. ¨My testimony with you is truly professional, with a positive response regarding the follow-up of the article and its review, you took into account my qualities and the importance of the topic¨.
Dear Dr. Jessica Magne, Editorial Coordinator 0f Clinical Cardiology and Cardiovascular Interventions, The review process for the article “The Handling of Anti-aggregants and Anticoagulants in the Oncologic Heart Patient Submitted to Surgery” was extremely rigorous and detailed. From the initial submission to the final acceptance, the editorial team at the “Journal of Clinical Cardiology and Cardiovascular Interventions” demonstrated a high level of professionalism and dedication. The reviewers provided constructive and detailed feedback, which was essential for improving the quality of our work. Communication was always clear and efficient, ensuring that all our questions were promptly addressed. The quality of the “Journal of Clinical Cardiology and Cardiovascular Interventions” is undeniable. It is a peer-reviewed, open-access publication dedicated exclusively to disseminating high-quality research in the field of clinical cardiology and cardiovascular interventions. The journal's impact factor is currently under evaluation, and it is indexed in reputable databases, which further reinforces its credibility and relevance in the scientific field. I highly recommend this journal to researchers looking for a reputable platform to publish their studies.
Dear Editorial Coordinator of the Journal of Nutrition and Food Processing! "I would like to thank the Journal of Nutrition and Food Processing for including and publishing my article. The peer review process was very quick, movement and precise. The Editorial Board has done an extremely conscientious job with much help, valuable comments and advices. I find the journal very valuable from a professional point of view, thank you very much for allowing me to be part of it and I would like to participate in the future!”
Dealing with The Journal of Neurology and Neurological Surgery was very smooth and comprehensive. The office staff took time to address my needs and the response from editors and the office was prompt and fair. I certainly hope to publish with this journal again.Their professionalism is apparent and more than satisfactory. Susan Weiner
My Testimonial Covering as fellowing: Lin-Show Chin. The peer reviewers process is quick and effective, the supports from editorial office is excellent, the quality of journal is high. I would like to collabroate with Internatioanl journal of Clinical Case Reports and Reviews.
My experience publishing in Psychology and Mental Health Care was exceptional. The peer review process was rigorous and constructive, with reviewers providing valuable insights that helped enhance the quality of our work. The editorial team was highly supportive and responsive, making the submission process smooth and efficient. The journal's commitment to high standards and academic rigor makes it a respected platform for quality research. I am grateful for the opportunity to publish in such a reputable journal.
My experience publishing in International Journal of Clinical Case Reports and Reviews was exceptional. I Come forth to Provide a Testimonial Covering the Peer Review Process and the editorial office for the Professional and Impartial Evaluation of the Manuscript.
I would like to offer my testimony in the support. I have received through the peer review process and support the editorial office where they are to support young authors like me, encourage them to publish their work in your esteemed journals, and globalize and share knowledge globally. I really appreciate your journal, peer review, and editorial office.
Dear Agrippa Hilda- Editorial Coordinator of Journal of Neuroscience and Neurological Surgery, "The peer review process was very quick and of high quality, which can also be seen in the articles in the journal. The collaboration with the editorial office was very good."
We found the peer review process quick and positive in its input. The support from the editorial officer has been very agile, always with the intention of improving the article and taking into account our subsequent corrections.
